Russell Investments Group
BOLD

Russell Investments Group’s Audentes Therapeutics, Inc BOLD Stock Holding History

Russell Investments Group’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-50,559
Closed -$3.02M – 3234
2019
Q4 		$3.02M Buy
50,559
+6,194
+14% +$232K 0.01% 1496
2019
Q3 		$1.25M Buy
44,365
+43,204
+3,721% +$1.47M ﹤0.01% 1902
2019
Q2 		$44K Sell
1,161
-145
-11% -$5.57K ﹤0.01% 2744
2019
Q1 		$51K Buy
+1,306
New +$37.4K ﹤0.01% 2801
2017
Q4 		– Sell
-28,840
Closed -$808K – 3046
2017
Q3 		$808K Buy
+28,840
New +$626K ﹤0.01% 2239

Russell Investments Group's BOLD Position: Q1 2020 in Review

Russell Investments Group sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 50,559 shares — an estimated $3.02M sold.

Russell Investments Group first reported a position in BOLD in Q3 2017 and held it in 5 quarters. The position peaked at $3.02M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Russell Investments Group reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Russell Investments Group sold 50,559 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $3.02M.
  • Russell Investments Group first reported a position in Audentes Therapeutics, Inc in Q3 2017 and held it in 5 quarters.
  • Russell Investments Group's Audentes Therapeutics, Inc position peaked at $3.02M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Russell Investments Group's 13F filing for Q1 2020, filed 6 May 2020.